Pasithea Therapeutics Files 2024 Annual Report
Ticker: KTTAW · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1841330
Sentiment: neutral
Topics: annual-report, 10-k, pharmaceuticals
TL;DR
Pasithea Therapeutics filed its 2024 10-K. Check financials.
AI Summary
Pasithea Therapeutics Corp. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offices in Miami Beach, Florida, operates in the pharmaceutical preparations sector. The filing, identified by accession number 0001013762-25-001646, was submitted on March 24, 2025.
Why It Matters
This 10-K filing provides a comprehensive overview of Pasithea Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Pasithea Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed within the 10-K filing.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- March 24, 2025 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Pasithea Therapeutics Corp. (company) — Registrant
- 0001013762-25-001646 (other) — Accession Number
- 20241231 (date) — Fiscal Year End
- 20250324 (date) — Filing Date
- Miami Beach, Florida (location) — Principal Executive Offices
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-40804 (other) — Commission File Number
FAQ
What is the primary business of Pasithea Therapeutics Corp. as indicated in the filing?
Pasithea Therapeutics Corp. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.
What is the fiscal year end for which this 10-K report is filed?
The 10-K report is filed for the fiscal year ended December 31, 2024.
Where are Pasithea Therapeutics Corp.'s principal executive offices located?
The principal executive offices of Pasithea Therapeutics Corp. are located at 1111 Lincoln Road, Suite 500, Miami Beach, Florida 33139.
What is the Commission file number for Pasithea Therapeutics Corp.?
The Commission file number for Pasithea Therapeutics Corp. is 001-40804.
On what date was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on March 24, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding Pasithea Therapeutics Corp. (KTTAW).